Emerald Advisers, LLC Travere Therapeutics, Inc. Transaction History
Emerald Advisers, LLC
- $2.41 Billion
- Q3 2024
A detailed history of Emerald Advisers, LLC transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Emerald Advisers, LLC holds 1,960,659 shares of TVTX stock, worth $36 Million. This represents 1.14% of its overall portfolio holdings.
Number of Shares
1,960,659
Previous 1,637,146
19.76%
Holding current value
$36 Million
Previous $13.5 Million
103.83%
% of portfolio
1.14%
Previous 0.6%
Shares
6 transactions
Others Institutions Holding TVTX
# of Institutions
184Shares Held
89.5MCall Options Held
137KPut Options Held
181K-
Black Rock Inc. New York, NY7.64MShares$140 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY7.5MShares$138 Million0.8% of portfolio
-
Deep Track Capital, LP Greenwich, CT7.37MShares$135 Million1.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.62MShares$122 Million0.0% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD4.48MShares$82.3 Million1.14% of portfolio
About Travere Therapeutics, Inc.
- Ticker TVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,173,600
- Market Cap $1.18B
- Description
- Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...